SCHEINBERG DAVID A 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Jun 14, 2018
Insider Transaction Report
Form 4
SCHEINBERG DAVID A
Director
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2018-06-13+25,000→ 25,000 totalExercise: $8.99From: 2018-06-13Exp: 2028-06-13→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This stock option becomes exercisable immediately on the date of grant.